SPP1, secreted phosphoprotein 1, 6696

N. diseases: 824; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE Inhibitive Effects of Huashi Pill on Formation of Renal Stones by Modulating Urine Biochemical Indexes and Osteopontin in Renal Stone Rat Models. 31690714 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 AlteredExpression disease BEFREE Taken together, our findings suggest that gallotannin can contribute to nephrolithiasis prevention via direct effects on renal epithelial cells including suppression of COM binding and MCP-1 and OPN expression, along with augmenting antioxidant activity. 22466558 2012
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 AlteredExpression disease BEFREE Activation of liver X receptor suppresses osteopontin expression and ameliorates nephrolithiasis. 30623435 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 AlteredExpression disease BEFREE The aim of the study was assessment of four selected macromolecules level: osteopontin, calgranulin, uromodulin and bikunin in fresh morning urine sample in children with nephrolithiasis in the course of idiopathic hypercalciuria. 29353465 2018
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE In addition, OPN is associated with renal stones, but whether it acts as a promoter or inhibitor of stone formation is controversial. 11703581 2001
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 AlteredExpression disease BEFREE Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo. 30720053 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 AlteredExpression disease BEFREE The purpose of this study is to evaluate the correlation between urinary OPN level and kidney stone formation and effect of nutrition on OPN level in nephrolithiasis. 30114399 2018
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE Here, we investigated the effects of different phosphorylated states of a synthesized peptide of OPN (the ASARM peptide; acidic, serine- and aspartate-rich motif) on calcium oxalate dihydrate (COD) crystals, a major mineral phase of kidney stones. 30016645 2018
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE Based on these data, it is proposed that during urolithiasis, secretion of osteopontin (uropontin) and osteocalcin (or osteocalcin-related gene/protein), and the subsequent incorporation of these proteins into kidney stone matrix, may influence the nucleation, growth processes, aggregation, and/or tubular adhesion of renal calculi in mammalian kidneys. 8619372 1995
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE We previously reported the potential therapeutic role of osteopontin (OPN) and macrophages in CaOx kidney stone formation, discovered using genome-recombined mice and genome-wide analyses. 27297950 2017
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE The Effects of Melatonin on Ethylene Glycol-induced Nephrolithiasis: Role on Osteopontin mRNA Gene Expression. 27717860 2017
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease CTD_human Phosphate is a specific signal for induction of osteopontin gene expression. 10890885 2000
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 GeneticVariation disease BEFREE SPP1 polymorphisms were found to be associated with nephrolithiasis and it may be suggested that SPP1 gene polymorphism could be a useful marker for evaluation of the early genetic risk factor in childhood nephrolithiasis. 23235966 2012
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE Calcium oxalate dihydrate (COD) mineral and the urinary protein osteopontin/uropontin (OPN) are commonly found in kidney stones. 19581305 2009
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease BEFREE Here, we quantitatively investigate the role of phosphorylation in interactions with calcium oxalate monohydrate crystals (COM), using synthetic peptides corresponding to the sequence 220-235 in osteopontin, a major inhibitor of kidney stone-related COM formation. 30569197 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.600 Biomarker disease RGD Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. 21378157 2011
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 Biomarker disease RGD Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. 16651633 2006
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 Biomarker disease CTD_human Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. 16651633 2006
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 Biomarker disease BEFREE Elucidation of regulatory mechanisms for OPN induction in glioma cells should facilitate rational design of novel therapeutics for human malignant gliomas. 9615723 1998
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 Biomarker disease BEFREE The literature review suggests that OPN may play important roles in the development and progression of selected cancers of children and young adults, including acute lymphoblastic leukemia, malignant gliomas, AT/RT and Langerhans cell histiocytosis. 28326824 2017
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 Biomarker disease BEFREE Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process. 30140373 2018
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 AlteredExpression disease BEFREE Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy. 23891093 2013
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 AlteredExpression disease BEFREE Our findings show re-activation of the embryonic-type transcriptional regulation of SPP1 in malignant gliomas and point to the importance of SPP1-CD44 interactions in self-renewal and pluripotency glioma initiating cells. 28030801 2017
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.560 AlteredExpression disease BEFREE Five potential markers (CD44 antigen (CD44), growth arrest and DNA-damage-inducible, alpha (GADD45A), fibronectin 1 (FN1), CD63 antigen (CD63) and secreted phosphoprotein 1 (SPP1)) showed expression patterns that correlated significantly with malignant glioma. 20150644 2010
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
0.500 AlteredExpression disease BEFREE Glomerular expression of osteopontin in biopsies of human crescentic glomerulonephritis (N = 25), IgA nephropathy with crescents (N = 2), and diffuse proliferative lupus glomerulonephropathy with crescents (N = 1) was studied by immunohistochemistry, in situ hybridization, and combined immunohistochemistry/in situ hybridization. 10620192 2000